(MENAFN- EQS Group) BodySmart Finance Limited
(the " Issuer ")
(incorporated with limited liability in the Bailiwick of Jersey with registered number 131386)
44 Esplanade, St Helier, Jersey, JE4 9WG
BodySmart Finance Limited - Coupon Payment Announcement
3rd June 2021
BodySmart Finance Limited Series 2020-B1 12.00% Fixed Rate Bonds Due 2025
(ISIN: GB00BMQ56V55)
(the " Bonds ")
The Issuer is pleased to announce that it has paid, in full and on time, the coupon due to bondholders on 3rd June 2021, under its secured Medium Term Note Bond Programme.
This is the Issuer's second coupon payment. The next coupon payment is due on 3rd December 2021.
BodySmart Investment Group's (the "Borrower") trading activities are focused on the medical, aesthetic and wellness industry - a sector on the rise in the Middle East. The Borrower already owns a successful portfolio of cosmetic clinics and wellbeing studios and since the issuance of the Bonds, the Borrower has continued to grow and develop the business. Recent highlights include:
- Despite the Covid effected environment, the Borrower's medical equipment distribution business has seen enhanced activity (across multiple jurisdictions in the region). With specific demand in high value equipment that promote targeted weight-loss and skin-toning
- Dr. Tarek Bayazid, one of Dubai's premier plastic surgeons is now fully on-boarded and licensed to the Borrower's clinics. Dr. Bayazid, who has joined the team as a senior plastic surgeon, is known for his exemplary work, especially in facial rejuvenation and body contouring
The Borrower is regulated by the Dubai Health Authority and the Dubai Department of Economic Development. During the 2020/21 Covid impacted period, the Borrower's clinics and health clubs have passed all regular inspections and continue to experience good demand for their offerings.
The bonds are admitted to trading on the Frankfurt Open Market.
For the Distributor: Glenn Scott-Ellis
For the Arranger: Hesham Dahman
IMPORTANT INFORMATION
This announcement is not itself an offer for the sale of any Bonds. Investors should not subscribe for any Bonds referred to in this announcement except on the basis of information in the programme listing particulars which are available on request. The distribution of this announcement and other information in connection with any offer in certain jurisdictions may be restricted by law and persons who come into possession of this announcement or any document or other information referred to herein should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any jurisdiction.
This announcement does not constitute or form any offer or invitation to sell, or any solicitation of any offer to purchase any Bonds.
Any Bonds referred to herein will not be registered under the U.S. Securities Act of 1933, as amended, (the "Securities Act"). Subject to certain exceptions, such Bonds may not be offered, sold or delivered within the United States or to, or for the account or benefit of, U.S. persons. Any Bonds referred to herein are expected to be offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit .
MENAFN03062021004691010666ID1102206681
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.